الصفحة الرئيسية>>Signaling Pathways>> Membrane Transporter/Ion Channel>> iGluR>>Lanicemine dihydrochloride

Lanicemine dihydrochloride

رقم الكتالوجGC61842

Lanicemine (AZD6765) ثنائي هيدروكلوريد هو مانع قناة NMDA منخفض الاحتباس (Ki 0.56-2.1 ميكرومتر لمستقبل NMDA ؛ IC50s من 4-7 ميكرومتر و 6.4 ميكرومتر في خلايا البويضات CHO و Xenopus ، على التوالي).

Products are for research use only. Not for human use. We do not sell to patients.

Lanicemine dihydrochloride التركيب الكيميائي

Cas No.: 153322-06-6

الحجم السعر المخزون الكميّة
10mM (in 1mL DMSO)
59٫40
متوفر
5 mg
54٫00
متوفر
10 mg
94٫50
متوفر
25 mg
198٫00
متوفر
50 mg
324٫00
متوفر
100 mg
495٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Lanicemine (AZD6765) dihydrochloride is a low-trapping NMDA channel blocker (Ki of 0.56-2.1 µM for NMDA receptor; IC50s of 4-7 µM and 6.4 µM in CHO and Xenopus oocyte cells, respectively). Antidepressant effects[1].

Lanicemine produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects[1].Lanicemine (3, 10 or 30 mg/kg; intraperitoneal) not only engages brain circuits involved in the generation of gamma- electroencephalography (EEG), but also influences these networks independent of the broader systems-level disruptions typical of ketamine[1].

References:
[1]. Sanacora G, et al. Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacywith minimal psychotomimetic adverse effects. Mol Psychiatry. 2014 Sep;19(9):978-85.

مراجعات

Review for Lanicemine dihydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 10 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Lanicemine dihydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.